On February 2, 2026, the U.S. Food and Drug Administration (FDA) published its anticipated compliance program manual, Inspection of Medical Device Manufacturers (CP 7382.850), to explain how the ...
Manual and automated inspection technologies have their own advantages and limitations. Finished pharma product inspection requires stringent oversight that may be lacking in systems that rely on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results